Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  ResMed, Inc.    RMD

RESMED, INC.

(RMD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: June 2018 2019 2020 2021 2022 2023
Capitalization1 14 78517 49827 77630 667--
Entreprise Value (EV)1 14 87818 62228 48930 91530 44829 921
P/E ratio 47,3x43,6x45,0x44,9x42,5x37,3x
Yield 1,37%1,23%0,81%0,76%0,86%0,85%
Capitalization / Revenue 6,32x6,71x9,39x9,76x9,00x8,29x
EV / Revenue 6,36x7,14x9,63x9,84x8,93x8,09x
EV / EBITDA 21,9x23,5x29,5x29,6x27,2x24,5x
Price to Book 7,18x8,43x11,1x10,0x8,49x7,24x
Nbr of stocks (in thousands) 142 738143 393144 668144 915--
Reference price (USD) 104122192212212212
Last update 08/02/201807/25/201908/05/202001/07/202101/07/202101/07/2021
1 USD in Million
Estimates
Income Statement Evolution
Annual Income Statement Data
Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net sales1 2 3402 6072 9573 1423 4093 699
EBITDA1 6807929661 0451 1181 223
Operating profit (EBIT)1 5606418118949551 051
Operating Margin 23,9%24,6%27,4%28,5%28,0%28,4%
Pre-Tax Profit (EBT)1 5215197338729501 075
Net income1 316405622694754858
Net margin 13,5%15,5%21,0%22,1%22,1%23,2%
EPS2 2,192,804,274,714,985,67
Dividend per Share2 1,421,501,561,601,821,79
Last update 08/02/201807/25/201908/05/202001/07/202101/07/202101/07/2021
1 USD in Million
2 USD
Estimates
Balance Sheet Analysis
Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt1 92,81 124713248--
Net Cash position1 ----219745
Leverage (Debt / EBITDA) 0,14x1,42x0,74x0,24x-0,20x-0,61x
Free Cash Flow1 442390707763752865
ROE (Net Profit / Equities) 25,3%25,5%27,2%26,3%24,7%24,1%
Shareholders' equity1 1 2491 5882 2852 6343 0483 558
ROA (Net Profit / Asset) 15,6%14,7%14,3%16,1%16,2%17,0%
Assets1 2 0302 7564 3484 3094 6605 058
Book Value Per Share2 14,414,517,321,124,929,2
Cash Flow per Share2 3,543,185,515,845,79-
Capex1 62,668,795,383,497,5110
Capex / Sales 2,67%2,64%3,22%2,65%2,86%2,98%
Last update 08/02/201807/25/201908/05/202001/07/202101/07/202101/07/2021
1 USD in Million
2 USD
Estimates
Finances - Leverage
Financial data source
© 2021 S&P Global Market Intelligence
Key data
Capitalization (USD)
30 666 944 677
Net sales (USD)
2 957 013 000
Number of employees
7 770
Sales / Employee (USD)
380 568
Free-Float
77,0%
Free-Float capitalization (USD)
23 606 042 063
Avg. Exchange 20 sessions (USD)
94 041 452
Average Daily Capital Traded
0,31%
EPS & Dividend